Fineline Cube

Follow:
14389 Articles
CompanyDrug

Shanghai Fosun Pharmaceutical’s SBK010 Stroke Treatment Accepted for NMPA Review

Company

3D Medicines’ H1’24 Financials Reflect Increased Comprehensive Loss Amid Revenue Decline

Policy / Regulatory

China Sets New Management Measures for Investigator-Initiated Trials in Medical Institutions

Policy / Regulatory

China Unveils Medical Insurance Eligibility Management System for Designated Healthcare Personnel

CompanyDeals

OrbusNeich Medical Group Partners with Abbott’s CSI as Sole Distributor

CompanyDrug

Jacobio Pharma Receives NMPA Approval for Pan-KRAS Inhibitor JAB-23E73 Clinical Trial

CompanyDrug

AstraZeneca’s Tagrisso Secures FDA Approval for Unresectable Stage III EGFRm NSCLC

CompanyDeals

Jacobio Pharma Receives RMB 172 Million Milestone Payment from Allist Pharmaceuticals

CompanyDeals

Apeloa Pharmaceutical Partners with Biocre Tech to Boost Pharmaceutical Innovation

CompanyDeals

FDA Approves Cobenfy as Novel Schizophrenia Treatment with First-in-Decades Mechanism

Policy / Regulatory

Hunan Province Includes Fertility Treatments in Medical Insurance Coverage from October 2024

CompanyDeals

Shanghai Junshi Biosciences Inks Licensing Deal for IAMA-001 Nasal Spray with Nanjing JSIAMA